Back

Is SiGLT2i the treatment for diabetic cardiomyopathy?

13 May 2024 (08:30 - 08:42)
Organised by: Logo
Congress Presentation Part of: Heart failure management in the cardiometabolic era Comorbidities HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Joao Pedro Ferreira

University of Porto, Porto (Portugal)

3 More presentations in this session

Presentation thumbnail
Obese cardiomyopathy and the role of GLP-1
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
How to manage heart failure in uremic cardiomyopathy
Doctor I. Beldhuis (Groningen, NL)
Slides Video
Presentation thumbnail
Heart failure management in the cardiometabolic era - discussion
Video

Access the full session

Session thumbnail
Heart failure management in the cardiometabolic era
Video

The Event

Event poster

Heart Failure 2024

13 May 2024 08:30 CET
You may be interested in
thumbnail
Congress Session
Heart failure management in the cardiometabolic era
thumbnail
Congress Presentation
SGLT2 inhibitors and heart failure: mechanisms and clinical implications
thumbnail
Congress Presentation
Diabetic myocardial disorder: clinical significance and outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources